Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(24)00219-5
Publication URI: http://dx.doi.org/10.1016/s2213-8587(24)00219-5
Type: Journal Article/Review
Parent Publication: The Lancet Diabetes & Endocrinology
Issue: 10